Ypsomed Holding AG

LSE:0QLQ Stock Report

Market Cap: CHF 5.0b

Ypsomed Holding Valuation

Is 0QLQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0QLQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0QLQ (CHF363.5) is trading below our estimate of fair value (CHF463.82)

Significantly Below Fair Value: 0QLQ is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0QLQ?

Key metric: As 0QLQ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0QLQ. This is calculated by dividing 0QLQ's market cap by their current earnings.
What is 0QLQ's PE Ratio?
PE Ratio67x
EarningsCHF 74.39m
Market CapCHF 4.99b

Price to Earnings Ratio vs Peers

How does 0QLQ's PE Ratio compare to its peers?

The above table shows the PE ratio for 0QLQ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average35.4x
CTEC ConvaTec Group
38.8x20.2%UK£4.7b
AMS Advanced Medical Solutions Group
38.6x20.5%UK£430.0m
TSTL Tristel
28.7x17.5%UK£186.0m
SN. Smith & Nephew
35.6x22.7%UK£8.6b
0QLQ Ypsomed Holding
67x41.1%CHF 5.0b

Price-To-Earnings vs Peers: 0QLQ is expensive based on its Price-To-Earnings Ratio (67x) compared to the peer average (35.4x).

Price to Earnings Ratio vs Industry

How does 0QLQ's PE Ratio compare vs other companies in the European Medical Equipment Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0QLQ 67.0xIndustry Avg. 29.4xNo. of Companies9PE01632486480+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0QLQ is expensive based on its Price-To-Earnings Ratio (67x) compared to the European Medical Equipment industry average (29.4x).

Price to Earnings Ratio vs Fair Ratio

What is 0QLQ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0QLQ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio67x
Fair PE Ratio57.2x

Price-To-Earnings vs Fair Ratio: 0QLQ is expensive based on its Price-To-Earnings Ratio (67x) compared to the estimated Fair Price-To-Earnings Ratio (57.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0QLQ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 363.50
CHF 426.00
+17.2%
15.4%CHF 495.00CHF 303.00n/a5
Dec ’25CHF 357.00
CHF 426.00
+19.3%
15.4%CHF 495.00CHF 303.00n/a5
Nov ’25CHF 388.00
CHF 426.20
+9.8%
13.0%CHF 495.00CHF 326.00n/a5
Oct ’25CHF 414.38
CHF 426.20
+2.9%
13.0%CHF 495.00CHF 326.00n/a5
Sep ’25CHF 415.03
CHF 426.20
+2.7%
13.0%CHF 495.00CHF 326.00n/a5
Aug ’25CHF 400.50
CHF 378.00
-5.6%
13.8%CHF 430.00CHF 326.00n/a2
Jul ’25CHF 412.50
CHF 378.00
-8.4%
13.8%CHF 430.00CHF 326.00n/a2
Jun ’25CHF 381.21
CHF 362.00
-5.0%
13.3%CHF 430.00CHF 326.00n/a3
May ’25CHF 329.00
CHF 351.33
+6.8%
9.8%CHF 400.00CHF 324.00n/a3
Nov ’24CHF 250.50
CHF 320.00
+27.7%
3.1%CHF 330.00CHF 310.00CHF 388.002
Oct ’24CHF 269.50
CHF 315.00
+16.9%
4.8%CHF 330.00CHF 300.00CHF 414.382
Sep ’24CHF 250.00
CHF 288.33
+15.3%
4.6%CHF 300.00CHF 270.00CHF 415.033
Aug ’24CHF 256.00
CHF 288.33
+12.6%
4.6%CHF 300.00CHF 270.00CHF 400.503
Jul ’24CHF 269.83
CHF 288.33
+6.9%
4.6%CHF 300.00CHF 270.00CHF 412.503
Jun ’24CHF 248.50
CHF 276.67
+11.3%
6.1%CHF 300.00CHF 260.00CHF 381.213
May ’24CHF 208.99
CHF 226.67
+8.5%
6.8%CHF 240.00CHF 205.00CHF 329.003
Apr ’24CHF 191.57
CHF 223.33
+16.6%
5.9%CHF 235.00CHF 205.00CHF 358.463
Mar ’24CHF 183.02
CHF 223.33
+22.0%
5.9%CHF 235.00CHF 205.00CHF 365.003
Feb ’24CHF 185.89
CHF 223.33
+20.1%
5.9%CHF 235.00CHF 205.00CHF 304.053
Jan ’24CHF 169.01
CHF 200.00
+18.3%
13.4%CHF 230.00CHF 165.00CHF 304.003
Dec ’23CHF 198.80
CHF 206.67
+4.0%
14.3%CHF 230.00CHF 165.00CHF 304.003

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 20:08
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ypsomed Holding AG is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carla BänzigerBank Vontobel AG
Gaurav JainBarclays
Curtis MoilesBNP Paribas Exane